Desloratadine
Back to searchMolecule Structure
Scientific Name
Desloratadine
Description of the Drug
Desloratadine is a second generation tricyclic antihistamine used to treat seasonal and non seasonal allergic rhinitis, pruritus, and urticaria.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00967
http://www.drugbank.ca/drugs/DB00967
Brand Name(s)
Aerius, Clarinex, Desloratadine, Midetorin, Neoclarityn
Company Owner(s)
Organon Llc A Sub Of Organon And Co, Perrigo Llc, Organon Llc, Lupin Pharmaceuticals Inc, Sandoz Inc, Sun Pharmaceutical Industries Ltd, Merck Sharp And Dohme Corp, Dr Reddys Laboratories Ltd, Orbion Pharmaceuticals Private Ltd, Mylan Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Histamine H1 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL231 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4425 | |
| PharmGKB | PA164776964 | |
| Human Metabolome Database | HMDB0015102 | |
| DrugBank | DB00967 | |
| PubChem: Thomson Pharma | 14874264 | |
| PubChem | 124087 | |
| Mcule | MCULE-2975958622 | |
| NMRShiftDB | 60022219 | |
| LINCS | LSM-5887 | |
| Nikkaji | J574.133E | |
| BindingDB | 50073179 | |
| EPA CompTox Dashboard | DTXSID1044196 | |
| DrugCentral | 814 | |
| Metabolights | MTBLC291342 | |
| Brenda | 23330 | 194216 |
| ChemicalBook | CB3462564 | |
| Guide to Pharmacology | 7157 | |
| rxnorm | DESLORATADINE | CLARINEX |
| PubChem: Drugs of the Future | 12013632 | |
| ChEBI | 291342 | |
| ZINC | ZINC000000001261 |
